Lupin Appoints Diana Amador-Toro as Senior Vice President, Global Compliance

#Lupin #Appointments #LeadershipChanges

Source: Lupin

“Quality is one of the most critical pillars of our organization, and we are delighted to have a leader with Diana’s experience and track record of excellence come on board. We are confident that Diana’s passion for quality and developing talent will make a significant difference in our efforts to achieve the highest standards of quality and compliance.” - Vinita Gupta, CEO and Nilesh Gupta, MD, Lupin

April 2022 : Global pharma major Lupin Limited (Lupin) has recently announced the appointment of Diana Amador-Toro as Senior Vice President, Global Compliance. Diana will be responsible for leading Lupin’s Global Compliance function including Training, Internal Audit, and Investigations. She will be based in Lupin’s Somerset office in New Jersey, USA.

Diana is a senior leader with more than 38 years of field experience in the US FDA’s Office of Regulatory Affairs (ORA). She previously served in two leadership positions in ORA as the New Jersey District Director and as the Office of Pharmaceutical Quality Operations Division I Director. In these roles, she provided executive leadership in directing and managing FDA pharmaceutical inspectional and compliance activities. She has been recognized with numerous awards, including the U.S. FDA Commissioner’s Special Citation and FDA’s highest award, the Award of Merit.

Commenting on the appointment, Vinita Gupta, Chief Executive Officer and Nilesh Gupta, Managing Director, Lupin said, “Quality is one of the most critical pillars of our organization, and we are delighted to have a leader with Diana’s experience and track record of excellence come on board. We are confident that Diana’s passion for quality and developing talent will make a significant difference in our efforts to achieve the highest standards of quality and compliance.”